technology

As biomanufacturing embraces Industry 4.0, digital twins and AI control are essential. Advanced algorithms require high-fidelity data and precise execution.If AI is the brain of bioreactors, precision hardware is its nerves and muscles.Devoxin provides robust physical infrastructure to eliminate data distortion and execution errors at the source.

This article debunks the "simple scale-up" myth in fermentation, highlighting the core differences between shake flasks and industrial fermenters. It underscores that innovations like miniature bioreactors and AI-driven optimization are bridging lab-to-industry gaps, driving the sector toward precision and intelligence.

This article notes that the bioreaction industry is constrained by a rigid cost structure, with competition shifting to cost optimization. It breaks down key costs including substrates, energy, equipment, compliance and labor, analyzes cost-cutting points, and argues that refined full-link operation and professional solutions are critical. Future competitiveness lies in comprehensive cost control.

Biopharmaceutical production is moving toward intelligent and lean manufacturing. The integration of PAT and Digital Twin enables real-time monitoring and optimization of bioreactor processes. This paper reviews their applications, discusses the intelligent closed-loop control for robustness, yield and quality consistency, and analyzes implementation paths and challenges.

Continuous downstream purification is key to modern biomanufacturing, overcoming batch inefficiencies and enabling seamless integration with continuous upstream culture. This paper examines the technologies and strategies of continuous downstream processing (cDSP), analyzes its advantages in productivity, cost and flexibility, and discusses challenges in robustness, compliance and integration.

Perfusion culture, a core upstream bioreactor technology, boosts monoclonal antibody (mAb) productivity and quality. This paper reviews its recent advances, focusing on cell retention device innovations, optimized process control, and key considerations for large-scale commercialization, providing technical guidance for biopharmaceutical companies.